SpringLeaf Therapeutics Receives $15,000,000 Series A Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4e0f70ad-a4e6-42b2-aa8b-4eef4dd77742&Preview=1 - Date
5/12/2011 - Company Name
SpringLeaf Therapeutics - Mailing Address
8 St. Mary’s Street Boston, MA 02215 - Company Description
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. - Website
http://www.springleaftx.com - Transaction Type
Venture Equity - Transaction Amount
$15,000,000 - Transaction Round
Series A - Proceeds Purposes
We have achieved promising preclinical results to date and anticipate clinical testing to initiate in late 2012. With the support of our new and existing investors, SpringLeaf is well positioned to advance our proprietary program, transforming the way patients are treated. - M&A Terms
- Venture Investor
SR One - Venture Investor
Flybridge Capital Partners - Venture Investor
North Bridge Venture Partners
